These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 24376732
1. Spleen dynamic contrast-enhanced magnetic resonance imaging as a new method for staging liver fibrosis in a piglet model. Zhou L, Chen TW, Zhang XM, Li CJ, Yang ZF, Zeng NL, Wang LY, Li T, Wang D, Li J, Li CP, Li L, Xie XY. PLoS One; 2013; 8(12):e83697. PubMed ID: 24376732 [Abstract] [Full Text] [Related]
3. Spleen size measured on enhanced MRI for quantitatively staging liver fibrosis in minipigs. Chen XL, Chen TW, Li ZL, Zhang XM, Chen N, Zeng NL, Li H, Tang HJ, Pu Y, Li CP. J Magn Reson Imaging; 2013 Sep; 38(3):540-7. PubMed ID: 23349034 [Abstract] [Full Text] [Related]
4. [Application of dynamic contrast-enhanced magnetic resonance imaging in evaluating liver fibrosis]. Li XY, Xiong W, Han LJ, Zhang XL, Qiu SJ, Li SL. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1259-63. PubMed ID: 21764710 [Abstract] [Full Text] [Related]
12. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging. Li Z, Sun J, Chen L, Huang N, Hu P, Hu X, Han G, Zhou Y, Bai W, Niu T, Yang X. J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910 [Abstract] [Full Text] [Related]
13. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits. Liu HF, Wang Q, Du YN, Zhu ZH, Li YF, Zou LQ, Xing W. Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235 [Abstract] [Full Text] [Related]
14. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI. Wu Z, Cheng ZL, Yi ZL, Xie MW, Zeng H, Lu LJ, Xu X, Shen J. J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822 [Abstract] [Full Text] [Related]
17. Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials. Huh J, Ham SJ, Cho YC, Park B, Kim B, Woo CW, Choi Y, Woo DC, Kim KW. BMC Med Imaging; 2019 Nov 15; 19(1):89. PubMed ID: 31729971 [Abstract] [Full Text] [Related]
18. Spleen magnetic resonance diffusion-weighted imaging for quantitative staging hepatic fibrosis in miniature pigs: An initial study. Chen XL, Chen TW, Zhang XM, Li ZL, Li H, Zeng NL, Tang HJ, Pu Y, Chen N, Yang Q, Li L, Xie XY, Hu J. Hepatol Res; 2013 Nov 15; 43(11):1231-40. PubMed ID: 23421793 [Abstract] [Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Chen BB, Hsu CY, Yu CW, Wei SY, Kao JH, Lee HS, Shih TT. Eur Radiol; 2012 Jan 15; 22(1):171-80. PubMed ID: 21879400 [Abstract] [Full Text] [Related]
20. Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI. Xiao B, Wang P, Zhao Y, Liu Y, Ye Z. Medicine (Baltimore); 2020 May 29; 99(22):e20503. PubMed ID: 32481470 [Abstract] [Full Text] [Related] Page: [Next] [New Search]